Global pharmaceutical partnerships integrated through Biovac's continental manufacturing hub in Cape Town. From biotherapeutics to sterile filling — verified, auditable, compliant.
Technology transfer partnerships with global pharmaceutical leaders, routed through the Cape Town manufacturing hub.
mRNA Technology Transfer · USA
COVID-19 vaccine fill-and-finish for African Union. mRNA technology transfer. 100M+ annual doses.
Cape Town Manufacturing Hub
200,000L continental vaccine manufacturing facility. SAHPRA & FDA aligned. Full tech-transfer integration.
Hexavalent & IPV · France
Fully liquid hexavalent and IPV vaccine technology transfer. Established supply partnership for paediatric immunisation.
Zero-trust edge architecture ensuring absolute data integrity for SAHPRA GMP submissions, WHO Prequalification documentation, and PIC/S Annex 11 compliance. Serverless design eliminates the shared-infrastructure attack surface inherent in legacy CMS architectures — which recorded 11,334 vulnerabilities in the current fiscal year alone. POPIA Section 19 compliant and GAMP-5 "secure by design" by architecture, not configuration. Every batch record and deviation is cryptographically hashed and immutable (Annex 11 aligned).
Flexible partnership structures designed to meet your strategic objectives and accelerate your pipeline.
Leverage our facilities and expert teams for process development, clinical supply, and commercial-scale biomanufacturing.
Inquire about CDMOCollaborate on co-development of novel biologics and vaccines from late-stage research through regulatory approval.
Propose an AllianceEngage on technology in-licensing or out-licensing opportunities to accelerate next-generation therapies.
Discuss TechnologyJoin our growing ecosystem of global pharmaceutical partners and help build Africa's vaccine manufacturing capability.